SGLT-2-Inhibitoren — neues Wundermittel zur Behandlung des Diabetes mellitus Typ 2?
Crossref DOI link: https://doi.org/10.1007/BF03652232
Published Online: 2018-04-01
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sönnichsen, Andreas
Text and Data Mining valid from 2018-04-01
Version of Record valid from 2018-04-01
Article History
First Online: 1 April 2018